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Abstract
Breast cancer is the most common malignancy among Arab women in Eastern Mediterranean Region (EMR). The
incidence of breast cancer has substantially increased in recent years among this women population, especially
those younger than 50, and the incidence is expected to double by 2030. Considerable experimental evidence
supports the potential role of dietary habits and lifestyle in cancer etiology and cancer prevention. In this review
we examined the literature for evidence to link dietary choices and the rise in incidence and mortality of breast
cancer among women in EMR. A literature search was conducted in PubMed and Ovid MEDLINE databases up to
December 2017. The search terms used are breast cancer prevalence, breast cancer incidence worldwide, breast
cancer and: nutrition, protein intake, vitamin D intake, fat intake, phytoestrogens, EMR, Arab, Middle East, Gulf
countries, the UAE Arab women, breast cancer risk, diet, and chemoprevention. We found evidence to suggest
that there is an alarming epidemic of obesity among women in most of the EMR countries, especially Gulf Cooperation Council (GCC) countries. The rise in the new breast cancer cases among women could be attributed to
excess body weight. Their dietary pattern, which correlates with obesity, can be an important factor in the etiology of cancer. Although very few studies were found to support a direct causal relationship between obesity
and breast cancer in the EMR, circumstantial evidence clearly points to the possible role of the epidemic, obesity,
in this population and the startling rise in cases of breast cancer. Well-designed and systematic studies are urgently needed to conﬁrm these associations and to elucidate potential mechanisms. More urgently, calls to action are needed in many sectors and at all levels of society, to establish intensive strategies for reducing obesity
and promoting an overall healthy diet. Continued and expanded research on diet, lifestyle, and breast cancer risk
is urgently needed to build the foundation for future progress in evidence-based public health efforts.
Keywords: Arab women; breast cancer; chemoprevention; diet; Middle East; nutrition

dously to shed light on factors that are associated
with breast cancer. These ﬁndings were published by
the Collaborative Group on Hormonal Factors in Breast
Cancer and they have established an important role for
childbearing and breastfeeding on breast cancer risk.1
However, dietary factors can play a role in the etiology
of breast cancer.

Introduction
It is well documented that the risk factors for breast
cancer are mainly related to hormones through their
inﬂuence on growth of the mammary glands. The ﬁndings from the collaborative analysis of data that were
collected from a total of 47 epidemiological studies
conducted in 30 countries have contributed tremen1
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The Eastern Mediterranean region (EMR) encompasses 22 countries spanning from Morocco in the west
to Pakistan in the east, and contains a population of almost 600 million people. Like many other developing regions, the burden of disease in the EMR has shifted in the
past four decades from primarily communicable diseases
to noncommunicable diseases, such as cancer and cardiovascular diseases. This shift has been attributed to the escalating obesity rate, which is becoming a major public
health problem in the region and has been associated
with the population shift toward a westernized diet.
In this review, we are examining the literature for
evidence to link the changes in lifestyle and dietary
choices (including obesity, low fruit and vegetable intake, low level of physical activity, etc.) and the rise
in incidence and mortality of breast cancer among
women in the Middles East. Conversely, we will examine the literature for dietary intake by women in this
region of certain nutrients that will have chemopreventive roles against breast cancer.
Methods
A literature search was conducted in PubMed and Ovid
MEDLINE databases up to December 2017. The search
terms used: breast cancer prevalence, breast cancer
incidence worldwide, breast cancer and: nutrition, protein intake, vitamin D intake, Fat intake, phytoestrogens, EMR, Arab, Middle East, Gulf countries, the
UAE Arab women, breast cancer risk, diet, chemoprevention. A list of 54 articles were deemed to meet the
criteria and used for the review analysis. Additionally,
we used GLOBOCAN worldwide estimates of cancer
incidence and mortality produced by the International
Agency for Research on Cancer (IARC).
Results
Breast cancer incidence and mortality in EMR
Most of cancer deaths in WHO EMR are attributed to
lung and breast cancer.2 By and large, the breast cancer is the most common cancer among women in all
countries of EMR,3 ranking ﬁrst as the most frequent
carcinoma diagnosed among women, (summarized in
Table 1). Data from GLOBOCAN (2014) showed that
the ratio of mortality:cancer incidence in EMR mounting to more than 42% compared with <19% in the
United States and 31% worldwide (Table 2). In women,
the average breast cancer incidence in this region is
33.9% of total women cancers, with world agestandardized rate of 41.9 per 100,000 and 24% mortality rate (Table 3).
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Table 1. The Three Most Frequent Cancers in Women
by Total Number of Cases, in Eastern Mediterranean
Region by Country, 2012
Country

First

Second

Qatar
United Arab Emirates
Bahrain
Kuwait
Saudi Arabia
Libya
Lebanon
Islamic Republic of Iran
Oman
Tunisia
Jordan
State of Palestine
Egypt
Syrian Arab Republic
Morocco
Iraq

Breast
Breast
Breast
Breast
Breast
Breast
Breast
Breast
Breast
Breast
Breast
Breast
Breast
Breast
Breast
Breast

Colorectum
Thyroid
Colorectum
Colorectum
Colorectum
Colorectum
Colorectum
Colorectum
Thyroid
Colorectum
Colorectum
Colorectum
Liver
Colorectum
Cervix uteri
Leukemia

Pakistan
Yemen
Djibouti
Sudan
Afghanistan
Somalia
Total EMR

Breast
Breast
Breast
Breast
Breast
Breast
Breast

Lip, oral cavity
Leukemia
Cervix uteri
Cervix uteri
Cervix uteri
Cervix uteri
Colorectum

Third
Thyroid
Cervix uteri
Cervix uteri
Thyroid
Thyroid
Cervix uteri
NHL
Stomach
Colorectum
Cervix uteri
Thyroid
Thyroid
NHL
Leukemia
Colorectum
Brain, nervous
system
Cervix uteri
Thyroid
Ovary
Ovary
Corpus uteri
Esophagus
Cervix uteri

GLOBOCAN 2012 data are used, which are based on estimates of cancer incidence and mortality. This table is extracted from table 1 of Kulhanova et al.3
EMR, Eastern Mediterranean Region; NHL, non-Hodgkin lymphoma.

An earlier report (2002) from the IARC showed
breast cancer to be the most common cancer among
females in all the six Gulf Cooperation Council (GCC)
countries,4 with incidence rates ranging from 14.5%
of all women cancers in Oman to almost one-third in
Kuwait and Bahrain. Based on these data, the report
classiﬁed Kuwait, Bahrain, and Qatar as high-incidence
areas and the United Arab Emirates, Saudi Arabia, and
Oman as low incidence areas of the GCC region.
A later analysis (2009) of cancer data from the
GCC countries showed that breast cancer was still the
most common cancer among women with the same
Table 2. Breast Cancer: Estimated Incidence, Mortality,
and Prevalence in Eastern Mediterranean Region
Compared with Other Regions and Worldwide in 2012
Estimated numbers
(thousands)

Cases

Deaths

5-Year
prevalence

World
More developed regions
Less developed regions
WHO EMR
United States

1671
788
883
99
233

522
198
324
42
44

6232
3201
3032
348
971

Extracted from GLOBOCAN 2012, WHO, IARC. Bold emphasizes values
in EMR relative to other regions in the world.
IARC, International Agency for Research on Cancer.
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Table 3. Population Fact Sheet: WHO Eastern Mediterranean Region: Estimated Incidence, Mortality,
and a 5-Year Prevalence of Breast Cancer Compared with All Cancers in Women
Incidence

Breast cancer
All cancers, excluding
nonmelanoma skin

Mortality
a

5-Year prevalence
a

N

%

ASR (world)

N

%

ASR (world)

N

%

Proportions

99,284
292,677

33.9
100

41.9
126.2

42,228
176,139

24
100

18.6
79.4

347,565
732,587

47.4
100

171.8
362.1

Incidence and mortality data for all ages. A 5-year prevalence for adult population only. Bold emphasizes breast cancer values compared to the
values of all cancers.
a
ASR (world) and proportions per 100,000.
ASR, age-standardized rate.

trend of incidence rate among these countries, ranging
from 16.1% in Oman to 35.4% in Bahrain. The agestandardized incidence rate (per 100,000 population)
was the highest in Bahrain (46.4), followed by Kuwait
(44.3), and Qatar (35.5), whereas United Arab Emirates
(19.2), Oman (14.4), and Saudi Arabia (12.9).5 Peculiarly, most breast cancer cases reported were among
women younger than 50 years of age.6
Studies from Saudi Arabia reported a steady increase
in the prevalence of breast cancer diagnosis during
1990–2010.7,8 One study reported 1152 cases in 2008
increasing to 1308 cases in 2009 and 1473 in 2010,
with the average age at the diagnosis of breast cancer
at 48 years of age.7 Another study published in 2012,
on breast cancer in Saudi Arabia conﬁrmed that between years 2000 and 2007, there was a steady increase
in the incidence of malignant breast carcinoma from
23.5% to 47.2%.8 In Oman, 1294 cases of breast cancer
were reported in 2014 and 53.5% of them were below
50 years of age.9
In addition to being a country of high incidence
rate, a study showed that the breast cancer in Kuwait
appears to be biologically of a very aggressive type (overexpression of Her-2 and lack of estrogen receptor expression), accounting for the high mortality rate that
occurs in *43% of breast cancer patients.10 This study
also identiﬁed some of the risk factors of breast cancer
among these women to include high body mass index
(BMI), lack of regular exercise, early age at menarche,
late age at ﬁrst pregnancy, hormonal therapy, and frequent consumption of carbohydrate, sugar, animal fat,
and hydrogenated vegetable oil (margarine) with low
intake of fresh vegetables and olive oil.10
According to the Health Authority Abu Dhabi (HAAD)
report in 2008,11 breast cancer is one of the leading
cancers in the United Arab Emirates; considering cancer is the third top leading cause of death in the United
Arab Emirates. Most cases of breast cancer in the UAE

reported between 2005 and 2007 were among Arab
women, and 64% of breast cancer patients in United
Arab Emirates present with advanced cases of regional
node involvement and/or metastases compared with
only 20% in the United States.11
In a study comparing breast cancer picture in North
African countries, including Morocco, Algeria, Tunisia,
Libya, and Egypt to that in Western countries, the results showed that epidemiological features of breast
cancer were different. North African countries have
higher proportion of young patients. Notably, the incident rates of breast cancer among younger patients are
much higher compared with the older generation. That
difference was related to combined factors, including
the rapid change in the lifestyle, diet, and emerging reproductive behaviors, such as declining in number of
children, the increased age at ﬁrst pregnancy, and shorter
duration of breastfeeding.12 For instance, in Egypt, total
fertility rates were 6.0 children per woman in 1988
compared with 3.1 in 2008 and in Morocco 5.7 in
1980 compared with 2.5 in 2003.12
Diet and physical activity in EMR
Diet and physical activity are important risk factors and one-third of the breast cancer cases could be
prevented by lifestyle intervention through reducing
alcohol intake, increasing the fruit, vegetables, and vegetable oil intake in the diet, and increasing physical activity level.13 According to reports from the WHO and
IARC, approximately one third of deaths from cancer are attributed to ﬁve leading lifestyle and dietary
choices, including high BMI, low fruit and vegetable
intake, low level of physical activity, tobacco, and alcohol consumption.14,15 Although the tobacco and alcohol consumption is not much of a problem among
women in the Middle East region, because of religious
and societal traditions, the remaining factors are profoundly contributing to the increased deterioration in

Taha and Eltom; BioResearch Open Access 2018, 7.1
http://online.liebertpub.com/doi/10.1089/biores.2018.0004

76

the health of women population in this region, more
speciﬁcally to the rising incidence of breast cancer and
its dismal outcome.
With the sudden transition and the rapid change in
the economy, Eastern Mediterranean (Middle Eastern)
people change their traditional diet to a more westernized diet that has high energy and fat-rich food intake.
They also adopted eating out habits, and an increase in
food portion sizes in most countries in the EMR.16 It is
very apparent that with the rapid improvement in the
economy in these countries, people are becoming afﬂuent and are consuming diets high in saturated fat, cholesterol, salt, and reﬁned carbohydrates, and low in
polyunsaturated fats and ﬁber, along with a marked
sedentary lifestyle and increased stress.17 Low intake
of fruit and vegetables was reported in children and adolescents, as well as in adults in many countries in the
EMR. In general, the intake was lower than the recommended daily allowance (>400 g) in all age groups and
in both genders.16
Breast cancer and diet/physical activity in EMR
Breast cancer is the most frequently diagnosed cancer
among women in all 22 countries of the EMR3 and
obesity is a risk factor that is strongly associated with
breast cancer. Alarmingly, overweight and obesity are
at an extreme high level in many EMR countries, including Qatar, Kuwait, United Arab Emirates, Bahrain,
and Saudi Arabia (Table 4). These countries are among
the top 10 countries with the highest rates of obesity
worldwide.18 An increase of 4980 (2%) of new cancer
cases among adult men and 17,018 (7%) among adult
women in the region were attributed to excess body
weight.19 Dietary pattern, which correlates with obesity, can be an important cause of cancer, and lack of
physical activity can also contribute to postmenopausal
breast cancer. The increase in utilizing car transportation, the reduction in physically demanding occupations, the increasing use of domestic helpers, and
Table 4. Overweight-Obesity Prevalence (Female/Male)
in Some Gulf Cooperation Council Countries

BMI

United
Arab
Bahrain Emirates

Qatar

Kuwait

Oman

Saudi
Arabia

>25 (%) 67.4/61.0 69.7/66.9 64.1/57.9 79/69.5 47.8/43.4 63.8/63.1
>30 (%) 35.2/21.2 39.4/24.5 29.3/17.4 52.9/29.6 14.8/7.7 33.8/23.0
BMI >25 is overweight and >30 is obese. Source: Data from WHO
(2006).55
BMI, body mass index.

increasing degree of sedentary lifestyles, all have contributed to the dramatic decline in physical activity in
the EMR.16 The level of physical inactivity is one of
the highest worldwide, reaching almost 70% in Saudi
Arabia.20
Dietary intake and breast cancer chemoprevention
In general, dietary intake of certain nutrients can play
major roles in modifying breast cancer risk. Several
studies investigated the relation between some nutrients and breast cancer.
Dietary b-carotene and vitamin E and breast cancer
Diet rich in b-carotene and vitamin E, such as fruits,
vegetables, and vegetable oil, is considered protective
against breast cancer risk. Vitamin E is an antioxidant
that was shown to decrease the number of carcinogeninduced mammary tumors in laboratory animals. Altogether, b-carotene and vitamin E are considered the
strongest protective factors among numerous micronutrients.13
Vitamin D and calcium intake and breast cancer
Several studies suggested that there was no association
between vitamin D and calcium intake and breast cancer risk.21,22 However, a case–control study in Saudi
women showed that there is an inverse association between serum 25(OH)D (the active metabolite of vitamin D) concentrations and breast cancer risk.23
Dietary fat and protein intake and breast cancer
An association was found between protein intake and
breast cancer risk, as the high intake of red meat,
fresh and processed, increases the risk of breast cancer,
whereas the high intake of soy food and skim milk
reduces the risk.24 A prospective cohort study among
women showed that high consumption of red meat
during adolescence was associated with premenopausal
breast cancer. Whereas, replacing red meat with other
dietary protein sources in adolescence could decrease
the potential risk of premenopausal breast cancer.25
On the other hand, some studies pointed out that
there is a weak positive association between saturated
fat intake and breast cancer risk, especially among
postmenopausal women who never used hormone
therapy.26 In general, there are rather inconsistent reports on the association between fat intake and breast
cancer.27,28 For instance, outcomes from some case–
control studies have suggested a positive association
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between saturated fat intake and risk of breast cancer,
whereas other studies demonstrated a reduced risk
from total and polyunsaturated fat intake.29 Results
from the nurses study which compared nurses who
consumed low-fat diets with nurses who consumed
high-fat diets have concluded that no relationship
existed between the amount of fat consumed and the
risk of breast cancer.30 The Willett’s review of epidemiological studies of the relationship between diet and
breast and colon cancers suggested that there was a
null or weak association between dietary fat and breast
cancer.31 With regard to Arab women, a case–control
study investigating the association between dietary fat
and breast cancer in Saudi women, reported a signiﬁcant positive association between the intake of fats,
protein, and calories and risk of breast cancer.32
In comparison, dietary patterns and its association
to breast cancer have been investigated in several studies in the west. Among all the dietary factors that were
studied, alcohol consumption has been found frequently
to be signiﬁcantly associated with breast cancer.33 Plantbased diets, including fruits and vegetables were associated with a reduction in breast cancer risk as
compared with food rich in fat and meat. This could
be attributed to the role of ﬁber in fruit and vegetables
that bind with estrogens and lead to excretion.
Phytoestrogen compounds and breast cancer
Phytoestrogens, natural compounds that share chemical structure similar to estrogens are found mainly in
plants such as soy beans, red and yellow fruits and vegetables, ﬂaxseeds, and whole grains.34 Several classes
of phytoestrogens exist, which include isoﬂavones, stilbenes, coumestans, and lignans.35 Resveratrol, daidzein,
quercetin, and genistein represent four of the most
commonly ingested and most widely studied phytoestrogens.36 The average daily consumption of phytoestrogens among East and Southeast Asia is estimated
to be around 20–50 mg/day; whereas the daily consumption in the United States and Europe, respectively, is only 0.15–3 and 0.49–1 mg/day.37 According
to epidemiological studies, plasma levels of isoﬂavone
in Japanese men is *2 lM in contrast to *5 nM in
Finnish men; however, local tissue phytoestrogen concentrations are suggested to be two to three times
higher than plasma levels.36 Epidemiological studies
provided evidence that phytoestrogens have an effect
in reducing the incidence of breast cancer, especially
among Asians who have high dietary intake of isoﬂavonoids through their daily diet.38–40
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The notion that dietary and lifestyle factors may
be partially responsible for the low breast cancer risks
detected in Asian women is supported by observations
in Asian women who immigrate to Western countries.
The second- and third-generation descendants of women
who migrated from Asia to Western countries have
breast cancer risks similar to those of women in the
host country, suggesting that lifestyle and not genetic
factors explains the low breast cancer risk of women
in Asia.36,41 However, a review of 21 case–control and
15 prospective studies concluded that there is no clear
evidence that phytoestrogen intake inﬂuences the risk
of developing breast cancer.36,42
Mediterranean diet and chemopreventive
role on breast cancer
The dietary consumption of fruit, vegetables, grains, legumes, olive oil, and the moderate intake of red wine
provide high levels of different polyphenols and plant
bioactive compounds that can serve as antioxidants,
anti-inﬂammatory, and antitumor.43 Mounting evidence
points to the beneﬁcial and preventive role of the Mediterranean diet (MD) in the onset of cancer and other
diseases associated with increased level of inﬂammation, oxidative damage, and angiogenesis. A recent
meta-analysis of all the observational studies regarding
the adherence to the MD in relation to cancer risk44
showed that the MD is associated with a signiﬁcant reduction of overall risk of cancer incidence and mortality by 10%. A meta-analysis by Schwingshackl and
Hoffmann did not conﬁrm an effect of the MD on
the risk of breast cancer; however, a subgroup of case–
control study showed that the risk of breast cancer
could be reduced by 18% in women adhering to the
MD. Chemoprotective effect of the MD against breast
cancer seemed to depend on individual’s characteristics
and potential risk factors, such as obesity, physical activity, smoking, age at menarche, and menopausal status. Notably, the beneﬁcial effect of the MD on breast
cancer risk is observed only in normal weight, nonsmoking women and in women who did not present
an early menarche (<12 years of age).45
Nutrition and breast cancer management
Diet and nutritional status are not only important
factors in the etiology of breast cancer, but they are—
major determinants of prognosis and treatment outcome in breast cancer patients. Furthermore, scientiﬁc
observations support the idea that dietary supplement
can prevent breast cancer recurrences.

Taha and Eltom; BioResearch Open Access 2018, 7.1
http://online.liebertpub.com/doi/10.1089/biores.2018.0004

Not limited only to breast cancer, malnutrition is
frequently manifested in cancer patients, even at the
time of diagnosis. Its incidence varies between 31%
and 87%, depending on the stage, type, treatment, and
the individual patient.46,47 Weight loss can occur, as a
result of elevated energy requirements, low energy intake, or impaired absorption of nutrients. In cancer
patients, undernutrition may be due to various factors.
Inﬂammation and catabolism created by the tumor can
result in muscle wasting and weight loss,48 whereas
tumor gastrointestinal obstruction can impair food intake and absorption, as a result of dysphagia, pain,
and vomiting. In addition to this, the side effects of anticancer treatment, such as anorexia, nausea, vomiting,
oral and intestinal mucositis with dysphagia, diarrhea,
hemorrhoids, anal ﬁssures, and modiﬁcations in smell
and taste affect not only the total energy intake, but
also the nutrient absorption, compromising nutritional
status. Furthermore, the poor psychological state of
cancer patients can affect their energy intake.49,50 Malnutrition can impact disease progression and survival
in cancer patients. Substantial studies have shown
that weight loss in cancer is associated with poor prognosis, poor quality of life, lower activity level, increased
treatment-related adverse symptoms, and reduced tumor
response to therapy.51 Weight loss at diagnosis has also
been associated with shorter failure free and overall
survival (OS), being identiﬁed as an independent prognostic factor. However, when patients stop losing weight
they have better OS.52
Discussion
Socioeconomic development is usually associated with
increasing wealth, changing lifestyle, and disease pattern leading to increase in life expectancy. This association of changes, known as epidemiological transition,
is very well demonstrated in the Middle East, especially
in the Gulf States, which have experienced rapid socioeconomic changes during the last four decades. As food
habits trail changes in lifestyle, there has been a dramatic shift from the indigenous traditional healthy
diet, which was based on whole wheat ﬂour, ﬁsh,
milk, and dates toward an afﬂuent diet, which is rich
in total calories, meat, saturated fat. and reﬁned carbohydrates. This change in dietary habits, taking place in
parallel with reduced physical activity, may have contributed to the increase in the number of breast cancer
cases in the regions.53 Dietary fat has been proposed as
one of the etiologic factors for breast cancer.28 However, the relationship between fat intake and the risk
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of breast cancer has been examined in a number of
case–control and cohort studies. The ﬁndings reported
in the literature are not conclusive enough to establish a
pattern for the real cause of the disease.30,31
Conclusions and Implications
Globally there is sufﬁcient evidence to strongly support
the notion that overweight, obesity, and reduced physical activities have direct causal relationship to breast
cancer. Although very few studies are available to directly document such a relationship in the Arab world,
circumstantial evidence clearly points to the possible
role of the epidemic obesity in this population and the
startling rise in cases of breast cancer. Well-designed
and systematic studies are urgently needed to establish
these associations. Although this review has shown
that dietary habits and lifestyle have an inﬂuence on
the incidence of breast cancer, it is still evident that
the main etiological factors are hormone related. McDonald et al. have documented that the incidence rates of
breast cancer in women who immigrated to Canada
has remained the same as it is in their control groups
back home despite acquiring a Western lifestyle.54 Calls
to action are urgently needed in many sectors and at
all levels of society, to establish intensive strategies
and polices for reducing obesity and promoting physical activity. Strong and persistent efforts are also
needed to promote an overall healthy lifestyle with special emphasis on diet that is rich in fruit and vegetables
and whole grains and low in red meat and saturated
fats. Continued and expanded research on diet, lifestyle
and breast cancer risk is urgently needed to build the
foundation for future progress in evidence-based public health efforts in this region of the world.
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